Market Cap

Australian Pharmaceutical Industries Limited Market Capitalization:

A$753.8 Million

AUD as of March 1, 2022

US$550.2 Million

business Australian Pharmaceutical Industries Limited Company Profile

Australian Pharmaceutical Industries Limited Main Stock Listing

ASX: API

Market Capitalization History of Australian Pharmaceutical Industries Limited

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Distribution
Company Market Cap (USD)
McKesson Corporation $75.67 B
Cencora, Inc. $43.82 B
Cardinal Health, Inc. $23.31 B
Shanghai Pharmaceuticals Holding Co. Ltd $8.79 B
Sinopharm Group Co. Ltd $8.37 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Australian Pharmaceutical Industries Limited market cap

Date Market Cap YoY Change
Jan. 1, 2022 A$748.8 M 36.94%
Jan. 31, 2021 A$546.8 M -12.25%
Jan. 1, 2021 A$623.2 M 5.86%
Jan. 31, 2020 A$588.7 M -9.13%
Jan. 1, 2020 A$647.8 M -6.41%
Jan. 31, 2019 A$692.2 M 11.07%
Jan. 1, 2019 A$623.2 M -17.32%
Jan. 31, 2018 A$753.8 M 3.38%
Jan. 1, 2018 A$729.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Australian Pharmaceutical Industries Limited Categories

Australia languages Healthcare languages Medical Distribution
Australia Healthcare Australia Medical Distribution

Stocks & Indices

Australian Pharmaceutical Industries Limited has the following listings and related stock indices.


Stock: ASX: API

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.